CCA
NEO icon

Conestoga Capital Advisors’s NeoGenomics NEO Stock Holding History

Conestoga Capital Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,840
Closed -$260K – 143
2019
Q2 		$260K Sell
11,840
-6,660
-36% -$146K 0.01% 133
2019
Q1 		$379K Buy
+18,500
New +$321K 0.01% 110

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Conestoga Capital Advisors's NEO Position: Q3 2019 in Review

Conestoga Capital Advisors sold out of NeoGenomics (NEO) in Q3 2019, closing a stake of 11,840 shares — an estimated $260K sold.

Conestoga Capital Advisors first reported a position in NEO in Q1 2019 and held it in 2 quarters. The position peaked at $379K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Conestoga Capital Advisors reported no remaining NeoGenomics position as of Q3 2019 after selling out during the quarter.
  • Conestoga Capital Advisors sold 11,840 NeoGenomics shares in Q3 2019, an estimated $260K.
  • Conestoga Capital Advisors first reported a position in NeoGenomics in Q1 2019 and held it in 2 quarters.
  • Conestoga Capital Advisors's NeoGenomics position peaked at $379K in Q1 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Conestoga Capital Advisors's 13F filing for Q3 2019, filed 25 Oct 2019.